Bupropion Hydrochloride (sr) Tablet, Extended Release
Product Images NDC 43598-863

2 FDA label images from Dr. Reddy's Laboratories Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (sr) (NDC 43598-863). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion-150mg (Bupropion 150mg)

Bupropion-150mg (Bupropion 150mg)
Label for Bupropion Hydrochloride Extended-Release Tablets, USP (SR) 150 mg, oral tablet, extended release formulation by Dr. Reddy's Laboratories Inc. The label indicates a 60 tablet count with instructions for pharmacists to provide a Medication Guide. It includes a warning against use with Wellbutrin or other bupropion hydrochloride-containing medicines.*
FDA Label Image

Chemical Structure (Bupropion Str)

Chemical Structure (Bupropion Str)
Chemical structure of Bupropion Hydrochloride, showing its chemical groups and arrangement for the active ingredient in BUPROPION HYDROCHLORIDE (SR) 150 mg extended release tablets by Dr. Reddy's Laboratories Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.